Trials / Completed
CompletedNCT02268981
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Schön Klinik Berchtesgadener Land · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate the effects of a reservoir nasal cannula (Oxymizer®) compared to a conventional nasal cannula (CNC) in patients with idiopathic pulmonary fibrosis.
Detailed description
Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program. They will perform the following three interventions on consecutive days and will repeat them after a week. During these days the time table for prescribed physical activities and therapies will be kept in a comparable fashion. The following 3 interventions will be performed in randomized order: Day A: The Patient wears a conventional nasal cannula for 12 h with oxygen flow rate as prescribed during ADL Day B: The Patient wears the Oxymizer® with prescribed oxygen flow rate for 12 h during ADL Day C: The patient wears the Oxymizer® with a flow rate reduced by 1l/min in comparison to the prescribed oxygen flow rate, for 12h The following week the same measurements will be repeated. The mean of the corresponding two measures will be calculated for each approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Oxymizer® compared to CNC | Oxygen Saturation measurement for 12 h with CNC |
| DEVICE | Oxymizer® compared to CNC | Oxygen Saturation measurement for 12 h with Oxymizer® |
| DEVICE | Oxymizer® compared to CNC | Saturation measurement for 12 h with Oxymizer® by reduced flow rate (-1l/min) |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2014-10-20
- Last updated
- 2015-09-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02268981. Inclusion in this directory is not an endorsement.